MIRA INFORM REPORT

 

 

Report Date :

10.11.2012

 

IDENTIFICATION DETAILS

 

Name :

GEOLAB INDUSTRIA FARMACÊUTICA S.A

 

 

Registered Office :

 

Via Principal 1- B - S/Nº. - Quadra 08-B - Lotes 01 A 08,0 - Bairro Daia

 

 

 

 

Country :

Brazil

 

 

 

 

Financials (as on) :

31.12.2011

 

 

 

 

Date of Incorporation :

14.10.1999

 

 

 

 

Legal Form :

Privately Held Corporation

 

 

 

 

Line of Business :

Manufacture Of Pharmaceuticals.

 

 

 

 

No. of Employees :

930

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

BRAZIL - ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth to 2.7% for 2011 as a whole, though forecasts for 2012 growth are somewhat higher. Despite slower growth in 2011, Brazil overtook the United Kingdom as the world's seventh largest economy in terms of GDP. Urban unemployment is at the historic low of 4.7% (December 2011), and Brazil's traditionally high level of income inequality has declined for each of the last 12 years. Brazil's high interest rates make it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchanges markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint.

Source : CIA


Company name

 

GEOLAB INDUSTRIA FARMACÊUTICA S.A

 

 

ADDRESSES

 

MAIN ADDRESS:

VIA PRINCIPAL 1- B - S/Nº. - QUADRA 08-B - LOTES 01 A 08,0 - BAIRRO DAIA

ZIP CODE/CITY:

75133-590 - ANÁPOLIS/GO

 

 

PHONE:

62 4015-4061

E-MAIL:

keylla.gomes@geolab.com.br

WEB SITE:

www.geolab.com.br

 

BRANCHES:

 

NOT AVAILABLE.

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE OF PHARMACEUTICALS.

 

LEGAL FORM:

PRIVATELY HELD CORPORATION

 

 

INCORPORATION DATE:

14/10/1999

REGISTER DATE:

28/10/1999

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

03.485.572/0001-04

STATE REGISTER:

10.323.327-0

 

 

SHARE CAPITAL:

R$ 24.500.000,00

 

BOARD OF DIRECTORS:

 

 

 

GEORGE HAJJAR JUNIOR

PRESIDENT DIRECTOR

RIZEK MIKHAIL HAJJAR

DIRECTOR

ANDRE LUIZ HAJJAR

DIRECTOR

 

AUTHORIZED USE OF SIGNATURE:

 

THE DIRECTORS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

AMÉRICA ADMINISTRAÇÃO E PARTICIPAÇÕES LTDA

51,00%

SERRA DOURADA ADMINISTRAÇÃO E PARTICIPAÇÕES LTDA

30,00%

M-5 ADMINISTRAÇÃO E PARTICIPAÇÕES LTDA

9,00%

TRIO-H ADMINISTRAÇÃO E PARTICIPAÇÕES LTDA

5,00%

PALMARES ADMINISTRAÇÃO E PARTICIPAÇÕES LTDA

5,00%

 

AFFILIATES / SUBSIDIARIES:

 

A SCAN THROUGH OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR DIRECTORS HAS/HAVE THE FOLLOWING UNCONFIRMED HOLDINGS:

 

 

 SERRA DOURADA ADMINISTRACAO E PARTICIPACOES LTDA

 

 EPOCA CONSTRUTORA LTDA - EPP

 

 ANDISA ADMINISTRACAO E PARTICIPACOES LTDA - EPP

 

 SOGAL ADMINISTRACAO E PARTICIPACOES LTDA - EPP

 

 AUTO TOCANTINS COMERCIO DE PECAS PARA VEICULOS LTDA - ME

 

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON OCTOBER 14, 1999 AS GEOLAB INDUSTRIA FARMACEUTICA E COSMETICA LTDA ME TO BE ENGAGED IN THE SAID LINE OF BUSINESS. ON OCTOBER 21, 2008 IT ALTERED TO GEOLAB INDUSTRIA FARMACEUTICA LTDA. ON JUNE 22, 2010 IT ADOPTED THE ABOVE-MENTIONED NAME.

 

TRADE NAME: "GEOLAB".

 

SHAREHOLDERS / PARTNERS:

 

ANDRÉ LUIZ HAJJAR: BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS CPF 617.296.121-72, RG 2.544.923 SSP/GO, RESIDENTIAL ADDRESS AT RUA 1 QUADRA 02, LOTES 01/02, APTO 800, ED. SERRA DOURADA - CIDADE JARDIM, ZIP ODE 75080-690, ANÁPOLIS/GO;

 

RIZEK MIKHAIL HAJJAR: BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS CPF 003.045.731-91, RG 43.841 SSP/GO, RESIDENTIAL ADDRESS AT RUA 1º. DE MAIO, 26, CENTRO, ZIP CODE 75020-050, ANÁPOLIS/GO.

 

FURTHER DETAILS ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

1

MUNICIPAL LAWSUIT

08/11/11

VARA DE ITAPEVI/SP

 

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2011, 31/12/2010 AND 31/12/2009.

( FIGURES ARE IN REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2011

31/12/2010

31/12/2009

 

 

 

 

CASH AND CASH EQUIVALENTS

6.825.330,51

12.335.543,19

5.659.299,80

CLIENTS

27.659.685,25

20.706.969,64

18.075.097,73

INVENTORY

22.883.817,37

12.124.795,95

11.281.283,07

ADVANCES

35.644,85

 

268.746,13

PREPAID EXPENSES

65.492,11

19.861,77

30.978,31

RECOVERABLE TAXES

3.110.074,78

1.244.755,52

1.225.039,41

ACCOUNTS RECEIVABLE

500.000,00

1.000.000,00

 

ADVANCE TO SUPPLIERS

4.525.439,74

1.261.774,23

 

ADVANCE TO EMPLOYEES

 

41.720,13

 

CONCESSIONAIRES

26.760,47

 

 

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

65.632.245,08

48.735.420,43

36.540.444,45

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

INVESTMENTS

 

315.847,89

333.906,81

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

 

315.847,89

333.906,81

 

FIXED ASSETS:

 

 

 

 

 

 

 

FIXED ASSETS

39.865.230,91

27.105.394,82

22.006.381,64

INVESTMENTS

310.902,48

 

 

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

40.176.133,39

27.105.394,82

22.006.381,64

 

================

================

================

TOTAL ASSETS

105.808.378,47

76.156.663,14

58.880.732,90

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2011

31/12/2010

31/12/2009

 

 

 

 

SUPPLIERS

6.852.720,66

6.658.141,19

5.787.214,95

LOANS AND FINANCING

9.577.898,98

4.887.213,59

1.350.926,20

TAXES & CONTRIBUTIONS

2.266.723,35

2.739.038,37

1.894.474,69

ACCOUNTS PAYABLE

891.771,76

749.344,85

451.376,57

BANKING DEBTS

 

2.646,19

35.920,45

PROFIT SHARING

5.973.511,85

1.340.000,00

 

OTHER DEBTS

426.335,00

 

7.743,50

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

25.988.961,60

16.376.384,19

9.527.656,36

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

13.695.955,85

4.215.666,86

6.387.511,04

INSTALLMENTS TAXES PAYABLE

1.036.660,14

1.052.084,56

1.077.895,64

ACCOUNTS PAYABLE

15.993.394,68

15.993.394,68

10.680.956,24

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

30.726.010,67

21.261.146,10

18.146.362,92

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

24.500.000,00

4.500.000,00

4.500.000,00

RESOURCE/INCREASE CAPITAL

 

 

20.500.000,00

ACCRUED PROFIT (LOSS)

 

 

6.206.713,62

LEGAL RESERVES

1.386.196,71

575.621,00

 

PROFIT RESERVES

 

33.443.511,85

 

RESERVES/TAX INCENTIVES

5.806.271,05

 

 

PROFIT RESERVES

17.400.938,44

 

 

 

----------------

----------------

----------------

TOTAL NET EQUITY

49.093.406,20

38.519.132,85

31.206.713,62

 

================

================

================

TOTAL LIABILITIES

105.808.378,47

76.156.663,14

58.880.732,90

 

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2011, 31/12/2010 AND 31/12/2009.

( FIGURES ARE IN REAIS ).

 

 

31/12/2011

31/12/2010

31/12/2009

 

 

 

 

GROSS SALES

129.505.876,60

116.414.839,81

85.008.028,12

(-) TAXES ON SALES

19.966.950,58

16.211.440,95

11.807.875,13

 

----------------

----------------

----------------

NET SALES

109.538.926,02

100.203.398,86

73.200.152,99

(-) COST OF SOLD GOODS

51.874.170,42

57.717.417,49

48.328.320,50

 

----------------

----------------

----------------

GROSS PROFIT

57.664.755,60

42.485.981,37

24.871.832,49

OPERATING REVENUE (EXPENSE)

-34.846.197,50

-24.329.643,94

-14.067.618,75

FINANCIAL REVENUE(EXPENSE)

-1.291.725,36

-835.020,29

-1.171.085,60

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

21.526.832,74

17.321.317,14

9.633.128,14

NON-OPERATING RESULT

5.806.271,05

242.499,88

 

CONTRIBUTION/INCOME TAX

-5.315.318,59

-6.051.397,79

-3.251.263,58

 

----------------

----------------

----------------

NET PROFIT (LOSS)

22.017.785,20

11.512.419,23

6.381.864,56

 

RATIOS:

31/12/2011

31/12/2010

31/12/2009

 

QUICK RATIO

1,64

 

2,24

 

2,65

 

CURRENT RATIO

2,53

 

2,98

 

3,84

 

ACCOUNTS RECEIVABLE TURNOVER

3,96

TIMES

4,84

TIMES

4,05

TIMES

DAYS' SALES IN RECEIVABLES

90,90

DAYS

74,39

DAYS

88,89

DAYS

INVENTORY TURNOVER

2,27

TIMES

4,76

TIMES

4,28

TIMES

ACCOUNTS PAYABLE PERIOD

47,56

DAYS

41,53

DAYS

43,11

DAYS

RETURN ON ASSETS

1,04

TIMES

1,32

TIMES

1,24

TIMES

SALES TURNOVER ON NET EQUITY

2,23

TIMES

2,60

TIMES

2,35

TIMES

NET WORTH TIE-UP

,81

 

,70

 

,71

 

INDEBTEDNESS

1,16

 

,98

 

,89

 

EQUITY RATIO

46,40

%

50,58

%

53,00

%

WORKING CAPITAL RATIO

152,54

%

197,60

%

283,52

%

GENERAL SOLVENCY

1,87

 

2,02

 

2,13

 

RETURN ON NET EQUITY

44,85

%

29,89

%

20,45

%

RETURN ON SALES (PROFIT MARGIN)

20,10

%

11,49

%

8,72

%

GROSS PROFIT MARGIN

52,64

%

42,40

%

33,98

%

OPERATIONAL RESULT

19,65

%

17,29

%

13,16

%

SALES TURNOVER ON LIABILITIES

4,21

TIMES

6,12

TIMES

7,68

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 2,03

 - OFFICIAL RATE ON 07/11/2012

US$ 1,00 = R$ 1,87

 - OFFICIAL RATE ON 31/12/2011

US$ 1,00 = R$ 1,66

 - OFFICIAL RATE ON 31/12/2010

US$ 1,00 = R$ 1,74

 - OFFICIAL RATE ON 31/12/2009

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS IS HIGH BUT IT IS NOTED GOOD LIQUIDITY RATIOS AND POSITIVE WORKING CAPITAL AMOUNT. IN ADDITION IT SHOWS GROWING SALES AND PROFITABILITY.

 

REAL ESTATE:

 

   OWNED PREMISES ARE VALUED AT R$ 14.552.515,04

 

VEHICLES:

 

   OWNED VEHICLES ARE VALUED AT R$ 133.676,51

 

MACHINES:

 

 OWNED MACHINES AND EQUIPMENTS ARE VALUED AT R$ 7.596.757,60

 

 

 

INSURANCE

 

NOT AVAILABLE.

 

 

BANKING REFERENCES:

 

 

BRANCH/PHONE:

CITY:

BANCO BRADESCO S/A

3684-6  / 62 3324-9118

GOIÂNIA/GO

BANCO DO BRASIL S/A

03388-X / 62 3311-1633

GOIÂNIA/GO

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

THE SUBJECT IS ENGAGED IN THE MANUFACTURE OF PHARMACEUTICALS.

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

 

NOT AVAILABLE.

 

   EXPORTS TO:

NOT AVAILABLE.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

 

 

NOT AVAILABLE.

 

 

 

STAFF:

 

THE COMPANY HAS: 930 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT WAS ESTABLISHED IN 1999 BUT REMAINED DORMANT UNTIL SEPTEMBER 2004, WHEN IT STARTED OPERATING EFFECTIVELY. SO FAR IT OPERATES WITH GROWING SCALE OF ACTIVITIES, A CLEAR TRADE HISTORY ANO GOOD PAYMENT BEHAVIOR.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

THE LAWSUIT REPORTED IS NOT RELATED WITH TRADE DEBT. IT IS RELATED TO TAX DEBT THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID. NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUIT DOES NOT AFFECT THE COMPANY’S TRADE REPUTATION.

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

 

PHONE:

CARTOGRAFICA FENIX LTDA

 

31 3361-6199

COLORCON DO BRASIL LTDA

 

11 4612-4262

EMBALAGENS ALLBOX LTDA

 

62 3311-4728

GALENA INDÚSTRIA QUIMICA FARMACEUTICA LTDA

 

19 3746-7730

GÊNIX INDÚSTRIA FARMACÊUTICA LTDA

 

0800-105008

GLOBE QUIMICA LTDA

 

 

KLOCKER PENTAPLAST DO BRASIL

 

11 4613-9976

PHARMA NOSTRA COMERCIAL LTDA

 

0800-7724880

 

PAYMENT HISTORY:

 

12 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 780.285,00

 

AMOUNT OF INVOICES PAID: 119

TOTAL OF PROMPT PAYMENTS: 100%

HIGHEST INVOICE: R$ 64.115,00

HIGHEST CREDIT: R$ 64.115,00

 

OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS:

 

---------------------------

SUPPLIERS:

INVOICES:

TOTAL AMOUNT:

DUE WITHIN 30 DAYS

1

1

R$ 26,00

 

 

FINAL OPINION

 

THE SUBJECT WAS ESTABLISHED IN 1999 BUT REMAINED DORMANT UNTIL 2004. SO FAR IT OPERATES WITH A GROWING SCALE OF ACTIVITIES AND FAVORABLE TRADE HISTORY.

 

BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.34

UK Pound

1

Rs.86.97

Euro

1

Rs.69.43

 

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.